UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
January 6, 2022 4:00 P.M.
Form:
F-1
CIK:
0001783036
Company Name:
NLS Pharmaceutics Ltd.
File Number:
333-261766